Skip to main content

PA Hospital Loses Bid For A New Trial In A $2.4M Verdict

PA Hospital Loses Bid For A New Trial In A $2.4M Verdict

Introduction

A state appeals court rejected a second bid by Pennsylvania’s Lehigh Valley Health Network Inc. for a new trial over a $2.4 million verdict awarded to a woman who was permanently disabled and confined to a wheelchair due to its employees’ negligence.

On April 12, 2012, the plaintiff underwent knee surgery at Lehigh Valley Hospital. She fell from the bed while recovering from the surgery and was transferred for occupational and physical therapy. The woman reported pain and clicking sound in her knee to a nurse, which was not reported to the treating doctor. The doctors, after finding that the woman suffered a fracture, performed two additional surgeries to fix her knee, both of which were unsuccessful. The woman has been left with a permanent disability and is confined to a wheelchair.

The woman filed a lawsuit against the hospital in February 2014, claiming negligence in connection with injuries suffered as well as a claim of loss of consortium.

A jury had awarded the women $2.4 million. The state's supreme court reversed the superior court’s prior decision and awarded the health-care provider a new trial, stating that some of the claims were time-barred.

On 26 May, the superior court said that the hospital wasn’t entitled to a new trial based on two alleged evidentiary errors, and the trial judge’s refusal to reduce the jury award.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.